PL327181A1 - Benzofurane carboxyamides and sulphonamides - Google Patents

Benzofurane carboxyamides and sulphonamides

Info

Publication number
PL327181A1
PL327181A1 PL96327181A PL32718196A PL327181A1 PL 327181 A1 PL327181 A1 PL 327181A1 PL 96327181 A PL96327181 A PL 96327181A PL 32718196 A PL32718196 A PL 32718196A PL 327181 A1 PL327181 A1 PL 327181A1
Authority
PL
Poland
Prior art keywords
sulphonamides
carboxyamides
benzofurane
carboxides
benzofuran
Prior art date
Application number
PL96327181A
Other languages
English (en)
Inventor
Hazel Joan Dyke
Hannah Jayne Kendall
Christopher Lowe
John Gary Montana
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9524832.4A external-priority patent/GB9524832D0/en
Priority claimed from GBGB9610515.0A external-priority patent/GB9610515D0/en
Priority claimed from GBGB9610712.3A external-priority patent/GB9610712D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of PL327181A1 publication Critical patent/PL327181A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL96327181A 1995-12-05 1996-12-05 Benzofurane carboxyamides and sulphonamides PL327181A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9524832.4A GB9524832D0 (en) 1995-12-05 1995-12-05 Novel compounds
GBGB9610515.0A GB9610515D0 (en) 1996-05-20 1996-05-20 Novel compounds
GBGB9610712.3A GB9610712D0 (en) 1995-12-05 1996-05-22 Novel compounds

Publications (1)

Publication Number Publication Date
PL327181A1 true PL327181A1 (en) 1998-11-23

Family

ID=27268015

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96327181A PL327181A1 (en) 1995-12-05 1996-12-05 Benzofurane carboxyamides and sulphonamides

Country Status (16)

Country Link
US (1) US5773467A (enExample)
EP (1) EP0873331B1 (enExample)
JP (1) JP2000501411A (enExample)
KR (1) KR19990071894A (enExample)
CN (1) CN1100773C (enExample)
AT (1) ATE215540T1 (enExample)
AU (1) AU697976B2 (enExample)
BR (1) BR9611897A (enExample)
CA (1) CA2238376C (enExample)
CZ (1) CZ292443B6 (enExample)
DE (1) DE69620458T2 (enExample)
ES (1) ES2172695T3 (enExample)
HU (1) HUP9903797A3 (enExample)
NO (1) NO982570L (enExample)
PL (1) PL327181A1 (enExample)
WO (1) WO1997020833A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972936A (en) * 1996-05-20 1999-10-26 Darwin Discover Limited Benzofuran carboxamides and their therapeutic use
ES2188983T4 (es) * 1996-08-19 2004-06-01 Altana Pharma Ag Nuevas benzofuran-4-carboxamidas.
JP3268236B2 (ja) 1997-07-22 2002-03-25 シャープ株式会社 電子写真感光体、及びビスヒドラゾン化合物およびその中間体、ならびにそれら化合物の製造方法
EP1029860B1 (en) 1997-10-01 2003-04-16 Kyowa Hakko Kogyo Co., Ltd. Benzofuran derivatives
AU1983599A (en) * 1998-01-26 1999-08-09 Kyowa Hakko Kogyo Co. Ltd. Oxygenic heterocyclic compounds
AU2529799A (en) * 1998-02-09 1999-08-23 Darwin Discovery Limited Benzofuran-4-carboxamides and their therapeutic use
FR2778662B1 (fr) * 1998-05-12 2000-06-16 Adir Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TW555759B (en) * 1998-06-08 2003-10-01 Darwin Discovery Ltd Heterocyclic compounds and their therapeutic use
WO1999064414A1 (de) * 1998-06-10 1999-12-16 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzamide mit tetrahydrofuranyloxy-substituenten als inhibitoren der phosphodiesterase 4
EP1671651B1 (en) 1999-08-21 2009-11-11 Nycomed GmbH Synergistic combination of pumafentrine and salmeterol
US7217722B2 (en) 2000-02-01 2007-05-15 Kirin Beer Kabushiki Kaisha Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
GB0011802D0 (en) * 2000-05-16 2000-07-05 Smithkline Beecham Method for enhancing cognitive function
JP2006522151A (ja) 2003-04-01 2006-09-28 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 不妊症におけるホスホジエステラーゼ阻害剤
FR2903106B1 (fr) * 2006-07-03 2010-07-30 Sanofi Aventis Utilisations de 2-benzoyl-imidazopyridines en therapeutique
EP2196465A1 (en) 2008-12-15 2010-06-16 Almirall, S.A. (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
AR074760A1 (es) * 2008-12-18 2011-02-09 Metabolex Inc Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
EP2226323A1 (en) 2009-02-27 2010-09-08 Almirall, S.A. New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
EP2380890A1 (en) 2010-04-23 2011-10-26 Almirall, S.A. New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
EP2394998A1 (en) 2010-05-31 2011-12-14 Almirall, S.A. 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
EP2597093B1 (en) 2010-07-22 2014-11-05 Fuso Pharmaceutical Industries, Ltd. Benzofuranone compound and pharmaceutical composition containing same
US10196372B2 (en) 2015-01-05 2019-02-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services MYC G-quadruplex stabilizing small molecules and their use
CN114149457B (zh) * 2021-11-03 2024-04-12 湖北民族大学 一种苯并[c][1,2]氧杂硼戊环-1(3H)-醇类合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8705871A1 (es) * 1984-12-29 1987-05-16 Kaken Pharma Co Ltd Un procedimiento para preparar un derivado de benzofurano
ES2127966T3 (es) * 1994-05-31 1999-05-01 Bayer Ag Derivados de amino-benzofurilo y -benzotienilo.
ES2152414T3 (es) * 1994-07-22 2001-02-01 Byk Gulden Lomberg Chem Fab Dihidrobenzofuranos.
WO1996036624A1 (en) * 1995-05-19 1996-11-21 Kyowa Hakko Kogyo Co., Ltd. Oxygen-containing heterocyclic compounds
US5972936A (en) * 1996-05-20 1999-10-26 Darwin Discover Limited Benzofuran carboxamides and their therapeutic use

Also Published As

Publication number Publication date
MX9804466A (es) 1998-12-31
CN1208411A (zh) 1999-02-17
CZ292443B6 (cs) 2003-09-17
NO982570L (no) 1998-08-04
EP0873331A1 (en) 1998-10-28
KR19990071894A (ko) 1999-09-27
AU697976B2 (en) 1998-10-22
AU1038697A (en) 1997-06-27
CA2238376C (en) 2006-08-15
NO982570D0 (no) 1998-06-04
CZ171498A3 (cs) 1998-10-14
CN1100773C (zh) 2003-02-05
JP2000501411A (ja) 2000-02-08
DE69620458D1 (de) 2002-05-08
WO1997020833A1 (en) 1997-06-12
ES2172695T3 (es) 2002-10-01
US5773467A (en) 1998-06-30
HUP9903797A2 (hu) 2001-04-28
HUP9903797A3 (en) 2001-08-28
CA2238376A1 (en) 1997-06-12
ATE215540T1 (de) 2002-04-15
BR9611897A (pt) 1999-12-28
DE69620458T2 (de) 2002-10-02
EP0873331B1 (en) 2002-04-03

Similar Documents

Publication Publication Date Title
PL327181A1 (en) Benzofurane carboxyamides and sulphonamides
AU5485698A (en) Oxyiminopregnancarbolactone
MY132705A (en) Novel compounds with analgesic effect
CA2199117A1 (en) Compounds and methods for the treatment of cancer
MY131298A (en) 5-heteroyl indole derivatives
AU3499395A (en) Ionene polymers containing biologically-active anions
CA2290520A1 (en) Inhibition of p38 kinase activity by aryl ureas
ATE236921T1 (de) L-ribavirin und dessen verwendung
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
AU6626696A (en) Quinolones and their therapeutic use
ATE203019T1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n- disubstituierte-amino-3,4-dihydro-2h-1- benzopyrane
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
MY103301A (en) Anti-inflammatory furanones
DE69713300D1 (de) Benzopyran derivate mit leukotrien-antagonistischer wirkung
MY133125A (en) Novel dihydroxyhexanoic acid derivatives
IL150125A0 (en) Novel compounds
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
WO1999057133A3 (en) Inhibitors of nf-kb activation
IL131478A0 (en) Methods for treatment of scar tissue
AU2596195A (en) Substituted alkyldiamine derivatives and their use as tachykinin antagonists
RU94024337A (ru) Антиметастатическое средство
FI965171A7 (fi) Oksatsofosforiinien, esimerkiksi ifosfamidin, enantiomeerien käyttö ka svainten hoidossa sivuvaikutuksien vähentämiseksi
AU5328800A (en) Use of interleukin-11 to treat hemorrhagic shock